Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Workday
WDAY
|
+$415M |
| 2 |
Atlassian
TEAM
|
+$397M |
| 3 |
TJX Companies
TJX
|
+$266M |
| 4 |
Corteva
CTVA
|
+$199M |
| 5 |
JPMorgan Chase
JPM
|
+$163M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.44B |
| 2 |
Microsoft
MSFT
|
+$1.41B |
| 3 |
Amazon
AMZN
|
+$657M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$564M |
| 5 |
Meta Platforms (Facebook)
META
|
+$537M |
Sector Composition
| 1 | Technology | 30.37% |
| 2 | Healthcare | 21.1% |
| 3 | Financials | 10.49% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Treace Medical Concepts
TMCI
$442M
| $9.53M | 0.01% |
664,651
-1,761
| -0.3% | -$25.3K |
|
702
Ollie's Bargain Outlet
OLLI
$7.95B
| $9.51M | 0.01% |
161,904
+143,765
| +793% | +$8.45M |
|
703
Ball Corp
BALL
$13.6B
| $9.51M | 0.01% |
138,292
-57,869
| -30% | -$3.98M |
|
704
Liberty Global Class A
LBTYA
$3.93B
| $9.46M | 0.01% |
449,327
+424,927
| +1,742% | +$8.95M |
|
705
Becton Dickinson
BDX
$54B
| $9.37M | 0.01% |
37,984
-78,171
| -67% | -$19.3M |
|
706
4D Molecular Therapeutics
FDMT
$324M
| $9.32M | 0.01% |
1,335,048
-330,363
| -20% | -$2.31M |
|
707
Canadian Imperial Bank of Commerce
CM
$73.3B
| $9.31M | 0.01% |
192,084
+32,612
| +20% | +$1.58M |
|
708
Keurig Dr Pepper
KDP
$37.3B
| $9.27M | 0.01% |
261,917
+110,080
| +72% | +$3.9M |
|
709
Ford
F
$45.5B
| $9.25M | 0.01% |
830,993
-1,315,114
| -61% | -$14.6M |
|
710
Phathom Pharmaceuticals
PHAT
$874M
| $9.22M | 0.01% |
1,092,212
-909,230
| -45% | -$7.67M |
|
711
Stem
STEM
$111M
| $9.2M | 0.01% |
64,231
-17,700
| -22% | -$2.53M |
|
712
ESSA Pharma
EPIX
$9.7M
| $9.17M | 0.01% |
2,909,410
-563,390
| -16% | -$1.78M |
|
713
Thermon Group Holdings
THR
$826M
| $9.1M | 0.01% |
647,293
-294,790
| -31% | -$4.14M |
|
|
ACC
714
DELISTED
American Campus Communities, Inc.
ACC
| $8.96M | 0.01% |
138,972
-123,640
| -47% | -$7.97M |
|
|
Y
715
DELISTED
Alleghany Corporation
Y
| $8.84M | 0.01% |
10,604
+7,157
| +208% | +$5.97M |
|
716
Scotiabank
BNS
$79.4B
| $8.8M | 0.01% |
149,110
-442,140
| -75% | -$26.1M |
|
717
Compass Therapeutics
CMPX
$604M
| $8.8M | 0.01% |
3,347,171
+153,877
| +5% | +$405K |
|
718
CSX Corp
CSX
$59.8B
| $8.7M | 0.01% |
299,023
-293,343
| -50% | -$8.53M |
|
719
HEICO Class A
HEI.A
$35B
| $8.68M | 0.01% |
82,443
+64,057
| +348% | +$6.75M |
|
720
Altria Group
MO
$111B
| $8.65M | 0.01% |
207,055
-122,908
| -37% | -$5.14M |
|
721
Rhythm Pharmaceuticals
RYTM
$6.66B
| $8.63M | 0.01% |
2,080,077
-870,925
| -30% | -$3.61M |
|
722
US Bancorp
USB
$76.6B
| $8.55M | 0.01% |
185,675
-73,768
| -28% | -$3.4M |
|
723
Conagra Brands
CAG
$9.27B
| $8.52M | 0.01% |
248,874
-1,511,999
| -86% | -$51.8M |
|
724
NeoGenomics
NEO
$966M
| $8.52M | 0.01% |
1,045,692
-3,239,416
| -76% | -$26.4M |
|
725
PPL Corp
PPL
$26.5B
| $8.5M | 0.01% |
313,230
+167,530
| +115% | +$4.54M |
|